GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MAOA, MCL1, MET, POLA1, POLB, PPARA, SRC, TRPV1, XDH |
11.6007 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, PTGES, TBXAS1, TRPV1 |
9.78379 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AXL, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, POLB, PPARA, PTGES, SRC, TRPV1, TYR |
9.46428 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, APP, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MCL1, MMP2, MMP9, POLB, PPARA, PTGES, SRC, TRPV1, TYR |
9.46428 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, APP, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MCL1, MMP2, POLB, PPARA, PTGES, SRC, TRPV1, TYR |
9.46428 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
8.81254 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.94706 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, POLB, SRC, TRPV1 |
7.74304 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, MCL1, MET, POLA1, POLB, SRC, TRPV1 |
7.62836 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
7.62836 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
7.62836 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
7.62836 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FUT7, HTR2B, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
7.34789 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC, TRPV1 |
7.24601 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.20341 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.16952 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FLT3, HTR5A, PTGES, SRC, TRPV1, TYR |
7.15933 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.15933 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.15933 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
7.00908 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
6.924 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
6.924 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MCL1, MMP2, MMP9, POLA1, POLB, PPARA, PTGES, SRC, TRPV1, TYR |
6.9085 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, TYR |
6.8607 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
6.70429 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A |
6.45292 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, PTGES, SRC, XDH |
6.45292 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX5, APP, AXL, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, TYR |
6.42286 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
6.42192 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MCL1, MET, SRC, XDH |
6.24538 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
6.24429 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
6.20855 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.20855 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGES, SRC |
6.014 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
6.01343 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC, TRPV1 |
5.88178 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.76847 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
5.69584 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
5.69584 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
5.67664 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
5.62614 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
5.58086 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, HTR5A, PTGES, SRC, TYR |
5.58086 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.58086 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, MET, PPARA, PTGES, TBXAS1 |
5.57201 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
5.55119 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
5.47862 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
5.36614 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, POLB, PPARA, SRC, TRPV1, TYR |
5.34897 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
5.31516 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
5.31391 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
5.22871 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA9, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MCL1, MET, MMP2, MMP9, PIM1, POLB, PPARA, SIGMAR1, SRC, TYR |
5.14916 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AXL, CA1, CA2, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MCL1, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTGES, SIGMAR1, SRC, TRPV1 |
5.11373 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SIGMAR1, SRC, TRPV1, XDH |
5.10961 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.06419 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.05424 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.02042 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.02042 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MCL1, MET, MMP2, MMP9, SRC, XDH |
5.01956 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PPARA, PTGES, TBXAS1 |
5.01539 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.97063 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SIGMAR1, SRC, TRPV1, XDH |
4.96146 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, MET, TRPV1 |
4.96146 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A, TRPV1 |
4.94975 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
4.94511 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
4.87239 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.87239 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR2A |
4.87239 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, SRC, TRPV1 |
4.7524 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, SRC, TRPV1 |
4.75225 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, TRPV1 |
4.62311 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, MAOA |
4.58148 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.58148 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2 |
4.55955 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
4.55338 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.53035 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.52819 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.50847 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.50847 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.49209 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A |
4.48053 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
4.47299 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, MCL1, MMP9, PIM1, SIGMAR1, SRC, TRPV1, XDH |
4.39127 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
4.3484 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.34701 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.32801 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
4.31427 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
4.31427 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.31427 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
4.31427 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AXL, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD11B1, HSD17B2, HTR5A, KDR, MCL1, MMP9, PIM1, POLB, PPARA, SIGMAR1, SRC, TYR |
4.28288 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.22343 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.20291 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM2, DRD1, DRD2, HTR2A, HTR2B |
4.17535 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
4.1408 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
4.12281 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, SRC, TBXAS1, TRPV1, TYR, XDH |
4.11811 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.10966 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
4.07266 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
4.025 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.98823 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.85675 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.80763 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
3.80671 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.79366 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, KDR, POLB, PPARA, SRC, TYR |
3.78285 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.76939 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.76939 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.76939 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, HTR5A, PPARA, SRC, TRPV1 |
3.68335 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR2A |
3.68335 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.66735 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, TRPV1 |
3.62291 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, SRC, TRPV1, TYR |
3.60568 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.59096 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.59096 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, TRPV1 |
3.59075 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, CYP3A4, MAOA |
3.55975 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.55975 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.55975 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC |
3.54162 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, TRPV1 |
3.54095 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
3.49431 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.43924 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, SIGMAR1, SRC, TRPV1, XDH |
3.40255 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.39058 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PPARA, PTGES, TBXAS1 |
3.34715 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.33723 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.33622 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP2, MMP9, PPARA, SRC, XDH |
3.33527 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA, TRPV1 |
3.33527 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, SRC |
3.32885 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.3207 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31466 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SRC |
3.27372 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
3.27277 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTGES, SRC, TRPV1, XDH |
3.25037 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, TRPV1 |
3.21611 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.21327 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.19132 |
[BP] GO:0099536 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.1485 |
[BP] GO:0099537 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.1485 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, CNR1, CNR2, DRD1, KDR, SRC, TRPV1 |
3.14156 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, KDR, SRC, XDH |
3.14156 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
3.12475 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
3.11707 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AXL, CA2, CNR1, CYP1B1, DRD2, DRD3, F3, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC, TRPV1 |
3.1069 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, CNR1, DRD2, DRD3, HTR2A, MMP9 |
3.10368 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.09615 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.09615 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
3.09615 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
3.08911 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC, TRPV1 |
3.06409 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, F3, FABP4, KDR, MET, PPARA |
3.03549 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, MCL1, POLA1, TRPV1 |
3.02089 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3 |
3.00412 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.00412 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.00412 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.00412 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, CNR1, DRD2, DRD3, PPARA |
2.99784 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGES |
2.99259 |
[BP] GO:0007610 |
None
|
APP, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA, TRPV1 |
2.97663 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.91153 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.91153 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MCL1, MMP2, MMP9, POLA1, POLB, PPARA, PTGES, SRC, TRPV1 |
2.91153 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.91005 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, MMP1, MMP2, PIM1, POLA1, POLB, PPARA, PTGES, SRC, TBXAS1, TYR, XDH |
2.90703 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.90396 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, PTGES |
2.90086 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.85631 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.84945 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.84945 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.84945 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
2.84285 |
[BP] GO:0050961 |
None
|
ADORA1, HTR2A, TRPV1 |
2.83977 |
[BP] GO:0050965 |
None
|
ADORA1, HTR2A, TRPV1 |
2.83977 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.83977 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.82426 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.80795 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR2A |
2.78665 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, SIGMAR1, SRC, TBXAS1, TRPV1, TYR, XDH |
2.76554 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.76175 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.76175 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.76094 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.76094 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.7497 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.74213 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MMP9, PIM1, SRC |
2.72451 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, SRC, XDH |
2.71392 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.70808 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, MMP9, PPARA, SRC, TRPV1 |
2.7024 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.68076 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, TRPV1 |
2.6639 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC |
2.64008 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, SRC, TRPV1 |
2.63818 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.62696 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.61932 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MCL1, MET, POLB, SRC |
2.61515 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.61515 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.60495 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.59139 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.58072 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, DRD1, DRD2, DRD3, HTR2A |
2.58009 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.58009 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.58009 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58009 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.58009 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.58009 |
[BP] GO:0016048 |
None
|
ADORA1, HTR2A, TRPV1 |
2.58009 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, SRC, XDH |
2.57591 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.57591 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, SRC |
2.57202 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.55649 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
2.54726 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.54726 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.54726 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, TRPV1 |
2.54726 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR2B, SRC, TRPV1 |
2.54565 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA |
2.5418 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.5418 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.5418 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.5418 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.5418 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.5418 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.53505 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.52538 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, SRC, TRPV1 |
2.52349 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, HTR7, PPARA, SRC |
2.50551 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.50374 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.49189 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.48631 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.48263 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTGES, SRC, TRPV1, XDH |
2.48165 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, POLB, PPARA, SRC |
2.4497 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.4497 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, IGF1R, MCL1, MET, MMP9, SRC, XDH |
2.4497 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.44378 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.44378 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.43227 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.4146 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
2.41331 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
2.41331 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.40262 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.40262 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.38972 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.38972 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.38972 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38972 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.38935 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.3847 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.35719 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.35719 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35719 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, CNR2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MCL1, MET, MMP9, SRC, XDH |
2.3558 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.34641 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.34641 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, CNR2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MCL1, MET, MMP9, SRC, XDH |
2.34527 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, HTR2B, SRC, TRPV1 |
2.34415 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, DRD2, F3, FABP4, IGF1R, MCL1, MET, MMP2, PPARA, SRC, XDH |
2.34205 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.33921 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, HTR2A, HTR2B, TRPV1 |
2.33921 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MCL1, MMP2, MMP9, POLA1, POLB, SRC, TRPV1 |
2.32824 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.3243 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, SRC |
2.29439 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC, TRPV1 |
2.27583 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, IGF1R, MCL1, MET, MMP9, PPARA, SRC, XDH |
2.27383 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.25813 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.25813 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.23729 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, SRC |
2.22869 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.22406 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.2239 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
2.22046 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.2199 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.18162 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.18162 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.18162 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.18162 |
[BP] GO:0071502 |
None
|
HTR2B, TRPV1 |
2.18162 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.18162 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.18162 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.18162 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.18162 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIM1, POLB, PPARA, SRC, TYR, XDH |
2.18162 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, CNR1, CYP1A1, HTR2A, POLB |
2.1533 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3 |
2.12835 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, DRD3, HTR2A |
2.11618 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, MAOA, XDH |
2.08886 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, SRC, TBXAS1, TRPV1, TYR, XDH |
2.08886 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SRC |
2.08689 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
2.07657 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, DRD3 |
2.06373 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, CNR1 |
2.06373 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.06373 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.06373 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC |
2.05824 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, PPARA, SRC, TRPV1 |
2.04874 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APP, AXL, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, SRC, TRPV1 |
2.04756 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, MCL1, MMP9, PPARA, SIGMAR1, SRC, TRPV1, XDH |
2.04597 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, TRPV1, TYR |
2.04237 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, CYP1A1, CYP1B1, DRD1, FLT3, SRC, TRPV1 |
2.04029 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.04029 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, DRD3 |
2.04029 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, DRD3 |
2.04029 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.04029 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.04029 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.04029 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.04029 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.04029 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.04029 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, AXL, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, DRD3, HTR2A, PTGES, SRC, TRPV1, TYR |
2.03204 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, TRPV1 |
2.0192 |
[BP] GO:0051781 |
None
|
AURKB, DRD2, DRD3, HTR2B |
2.01085 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DRD1, IGF1R, MMP2, MMP9, SRC, TRPV1 |
2.00685 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, HTR2A, HTR2B |
2.00685 |
[BP] GO:2001024 |
negative regulation of response to drug
|
CNR1, DRD2, MET |
2.00685 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA4, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
9.28193 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
7.41854 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, MMP2, PIM1, PTGES, SIGMAR1, SRC, TBXAS1, TRPV1, TYR |
7.0362 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, SIGMAR1, SRC, TBXAS1, TRPV1, TYR |
6.90351 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CA4, CA9, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC, TRPV1 |
6.42192 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AXL, CA12, CA14, CA4, CA9, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
5.46435 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, SRC, TRPV1 |
4.48053 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA12, CA14, CA9, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
4.17985 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.59096 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC, TRPV1 |
3.4129 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, F10, FLT3, HSD11B1, HSD17B2, PTGES, SIGMAR1, TBXAS1 |
3.37477 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, HSD11B1, HSD17B2, PTGES, SIGMAR1, TBXAS1 |
3.0581 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX5, APP, AURKB, CA1, CA2, CA4, CA7, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR2A, HTR5A, KDR, MAOA, MCL1, MMP2, MMP9, PIM1, POLA1, PTGES, SIGMAR1, SRC, TBXAS1, TRPV1, TYR, XDH |
2.66295 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, SIGMAR1, SRC, TRPV1 |
2.54726 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, SIGMAR1, SRC, TRPV1 |
2.54726 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.54726 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.5418 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CHRM2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, SRC |
2.41331 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.28037 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, SRC, TRPV1 |
2.27925 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.78379 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, SRC, TBXAS1, TRPV1, TYR, XDH |
9.78379 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, MMP1, MMP2, MMP9, PIM1, PPARA, TBXAS1, TYR, XDH |
9.33812 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
9.28846 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4 |
8.44975 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.43296 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.40608 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
8.25702 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
8.23845 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
8.23845 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC, TRPV1 |
7.94706 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
7.62836 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.51604 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
7.41587 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, TBXAS1, TRPV1, TYR, XDH |
7.22886 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
7.20153 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.19138 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, XDH |
7.15933 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
7.15933 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.15933 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.15933 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.11546 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.11546 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
6.81168 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.81168 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.65426 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.5435 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
6.33354 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, F10, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, SRC, TBXAS1, TYR, XDH |
6.18803 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
6.17982 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
5.80103 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
5.66421 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
5.37095 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.3371 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP2D6, CYP3A4 |
4.75905 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
4.52791 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.59096 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.43924 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.1445 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.09615 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.00412 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, F10, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, TBXAS1, TRPV1, TYR, XDH |
2.76094 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.59826 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.58009 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.58009 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.5418 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.35719 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.35719 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, HSD11B1, HSD17B1, HSD17B2, XDH |
2.24745 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.21819 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.18162 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.13967 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04029 |